Drug Profile
Cannabidiol topical - One World Cannabis
Alternative Names: Cannabis psoriasis cream; Medical grade cannabis ointment - One World Cannabis; MSG ointment; OWC MGC cream; OWC psoriasis creamLatest Information Update: 28 Sep 2022
Price :
$50
*
At a glance
- Originator One World Cannabis
- Class Analgesics; Anti-inflammatories; Anti-ischaemics; Antidementias; Antiemetics; Antiepileptic drugs; Antihyperglycaemics; Antineoplastics; Antiparasitics; Antiparkinsonians; Antipsoriatics; Antipsychotics; Antirheumatics; Anxiolytics; Appetite stimulants; Cannabinoids; Chromans; Cyclohexenes; Drug withdrawal therapies; Heart failure therapies; Hepatoprotectants; Muscle relaxants; Neuroprotectants; Non-opioid analgesics; Obesity therapies; Phytotherapies; Skin disorder therapies; Small molecules
- Mechanism of Action Cannabinoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Psoriasis
Most Recent Events
- 28 Sep 2022 No recent reports of development identified for phase-I development in Psoriasis(In volunteers) in Israel (Topical, Cream)
- 09 Sep 2020 Cannabidiol topical is still in phase I trial in Israel (One World Cannabis pipeline, September 2020)
- 16 Dec 2019 OWC Pharmaceutical Research receives patent allowance for cannabidiol topical in USA